1331 related articles for article (PubMed ID: 25421855)
1. Choroidal thickness measurement by enhanced depth imaging and swept-source optical coherence tomography in central serous chorioretinopathy.
Hamzah F; Shinojima A; Mori R; Yuzawa M
BMC Ophthalmol; 2014 Nov; 14():145. PubMed ID: 25421855
[TBL] [Abstract][Full Text] [Related]
2. Assessment of macular choroidal thickness by optical coherence tomography and angiographic changes in central serous chorioretinopathy.
Jirarattanasopa P; Ooto S; Tsujikawa A; Yamashiro K; Hangai M; Hirata M; Matsumoto A; Yoshimura N
Ophthalmology; 2012 Aug; 119(8):1666-78. PubMed ID: 22521082
[TBL] [Abstract][Full Text] [Related]
3. Optical coherence tomography-assisted enhanced depth imaging of central serous chorioretinopathy.
Yang L; Jonas JB; Wei W
Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4659-65. PubMed ID: 23737472
[TBL] [Abstract][Full Text] [Related]
4. Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy.
Maruko I; Iida T; Sugano Y; Ojima A; Sekiryu T
Retina; 2011 Sep; 31(8):1603-8. PubMed ID: 21487334
[TBL] [Abstract][Full Text] [Related]
5. Clinical and spectral-domain optical coherence tomography findings in patients with focal choroidal excavation.
Lee CS; Woo SJ; Kim YK; Hwang DJ; Kang HM; Kim H; Lee SC
Ophthalmology; 2014 May; 121(5):1029-35. PubMed ID: 24439757
[TBL] [Abstract][Full Text] [Related]
6. Focal choroidal excavation in eyes with central serous chorioretinopathy.
Ellabban AA; Tsujikawa A; Ooto S; Yamashiro K; Oishi A; Nakata I; Miyake M; Akagi-Kurashige Y; Ueda-Arakawa N; Arichika S; Yoshitake S; Takahashi A; Yoshimura N
Am J Ophthalmol; 2013 Oct; 156(4):673-83. PubMed ID: 23831223
[TBL] [Abstract][Full Text] [Related]
7. Subfoveal choroidal thickness after treatment of central serous chorioretinopathy.
Maruko I; Iida T; Sugano Y; Ojima A; Ogasawara M; Spaide RF
Ophthalmology; 2010 Sep; 117(9):1792-9. PubMed ID: 20472289
[TBL] [Abstract][Full Text] [Related]
8. Assessment of choroidal topographic changes by swept source optical coherence tomography after photodynamic therapy for central serous chorioretinopathy.
Razavi S; Souied EH; Cavallero E; Weber M; Querques G
Am J Ophthalmol; 2014 Apr; 157(4):852-60. PubMed ID: 24412124
[TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of neovascular and non-neovascular chronic central serous chorioretinopathy (CSC) diagnosed by swept source optical coherence tomography angiography (SS OCTA).
Sulzbacher F; Schütze C; Burgmüller M; Vécsei-Marlovits PV; Weingessel B
Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1581-1590. PubMed ID: 31037488
[TBL] [Abstract][Full Text] [Related]
10. Choroidal vessel diameter in central serous chorioretinopathy.
Yang L; Jonas JB; Wei W
Acta Ophthalmol; 2013 Aug; 91(5):e358-62. PubMed ID: 23647989
[TBL] [Abstract][Full Text] [Related]
11. Choroidal thickness and choroidal blood flow after intravitreal bevacizumab injection in eyes with central serous chorioretinopathy.
Okamoto M; Matsuura T; Ogata N
Ophthalmic Surg Lasers Imaging Retina; 2015 Jan; 46(1):25-32. PubMed ID: 25559505
[TBL] [Abstract][Full Text] [Related]
12. Choroidal thickness in central serous chorioretinopathy.
Kuroda S; Ikuno Y; Yasuno Y; Nakai K; Usui S; Sawa M; Tsujikawa M; Gomi F; Nishida K
Retina; 2013 Feb; 33(2):302-8. PubMed ID: 23064424
[TBL] [Abstract][Full Text] [Related]
13. Punctate hyperfluorescence spot as a common choroidopathy of central serous chorioretinopathy and polypoidal choroidal vasculopathy.
Park SJ; Kim BH; Park KH; Woo SJ
Am J Ophthalmol; 2014 Dec; 158(6):1155-1163.e1. PubMed ID: 25127698
[TBL] [Abstract][Full Text] [Related]
14. Choroidal thickness following extrafoveal photodynamic treatment with verteporfin in patients with central serous chorioretinopathy.
Pryds A; Larsen M
Acta Ophthalmol; 2012 Dec; 90(8):738-43. PubMed ID: 21586096
[TBL] [Abstract][Full Text] [Related]
15. OCT Angiography Compared to Fluorescein and Indocyanine Green Angiography in Chronic Central Serous Chorioretinopathy.
Teussink MM; Breukink MB; van Grinsven MJ; Hoyng CB; Klevering BJ; Boon CJ; de Jong EK; Theelen T
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5229-37. PubMed ID: 26244299
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of choroidal hyperreflective dots in acute and chronic central serous chorioretinopathy.
Hanumunthadu D; Matet A; Rasheed MA; Goud A; Vuppurabina KK; Chhablani J
Indian J Ophthalmol; 2019 Nov; 67(11):1850-1854. PubMed ID: 31638047
[TBL] [Abstract][Full Text] [Related]
17. Change of regional choroid thickness after reduced-fluence photodynamic therapy for chronic central serous chorioretinopathy.
Manabe S; Shiragami C; Hirooka K; Izumibata S; Tsujikawa A; Shiraga F
Am J Ophthalmol; 2015 Apr; 159(4):644-51. PubMed ID: 25595669
[TBL] [Abstract][Full Text] [Related]
18. En face enhanced-depth swept-source optical coherence tomography features of chronic central serous chorioretinopathy.
Ferrara D; Mohler KJ; Waheed N; Adhi M; Liu JJ; Grulkowski I; Kraus MF; Baumal C; Hornegger J; Fujimoto JG; Duker JS
Ophthalmology; 2014 Mar; 121(3):719-26. PubMed ID: 24289918
[TBL] [Abstract][Full Text] [Related]
19. Optical coherence tomographic enhanced depth imaging of polypoidal choroidal vasculopathy.
Yang LH; Jonas JB; Wei WB
Retina; 2013 Sep; 33(8):1584-9. PubMed ID: 23584691
[TBL] [Abstract][Full Text] [Related]
20. Chronic central serous chorioretinopathy imaged by optical coherence tomographic angiography.
Quaranta-El Maftouhi M; El Maftouhi A; Eandi CM
Am J Ophthalmol; 2015 Sep; 160(3):581-587.e1. PubMed ID: 26133250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
